Upper reference limits for cerebrospinal fluid total protein and albumin quotient based on a large cohort of control patients: implications for increased clinical specificity

Abstract Background: Determination of cerebrospinal fluid (CSF) total protein (TP) as well as of CSF/serum albumin quotient (Qalb) is part of the routine CSF work-up. However, currently used upper reference limits (URL) are not well validated leading to over-reporting of blood-CSF barrier dysfunction in approximately 15% of patients without neurological disease. The objective of this study was to determine age-related URL for CSF TP and Qalb in a cohort of control patients. Methods: A total of 332 paired CSF and serum samples of patients without objective clinical and paraclinical findings of a neurological disease were analyzed for CSF TP and Qalb. CSF TP was measured by spectrophotometry and albumin in CSF and serum by nephelometry. Results: CSF TP concentration and Qalb significantly correlated with age. In subjects at the age of 18–70 years, median CSF TP ranged from 320 to 460 mg/L and URL defined as the 95th percentile were 530–690 mg/L. Median Qalb ranged from 4.1 to 6.1 and URL from 8.7 up to 11.0. For URL of Qalb we calculated the following formula: age/25+8. Conclusions: Age-dependent URL for CSF TP and Qalb are presented here in a large cohort of control patients. They are higher than those currently recommended and this probably explains why isolated blood-CSF barrier dysfunction has been apparently over-reported. These new URL might be considered in a future revision of CSF guidelines.

[1]  S. Ohman,et al.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. , 1977, Scandinavian journal of clinical and laboratory investigation.

[2]  J. Kassubek,et al.  Isolated blood–cerebrospinal fluid barrier dysfunction: prevalence and associated diseases , 2005, Journal of Neurology.

[3]  O. Meulemans Determination of total protein in spinal fluid with sulphosalicylic acid and trichloroacetic acid. , 1960, Clinica chimica acta; international journal of clinical chemistry.

[4]  K. Blennow,et al.  Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. , 1993, European neurology.

[5]  E. Thompson,et al.  Proteins as parameters in the discrimination between different blood-CSF barriers , 1986, Journal of the Neurological Sciences.

[6]  G. Giovannonid,et al.  Guidelines on routine cerebrospinal fluid analysis . Report from an EFNS task force , 2006 .

[7]  C. Hommet,et al.  Total Protein Level in Cerebrospinal Fluid is Stable in Elderly Adults , 2013, Journal of the American Geriatrics Society.

[8]  C. Laurell,et al.  Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation. , 1974, Clinical chemistry.

[9]  M. Vijaya Lakshmi,et al.  Age-related changes in cerebrospinal fluid protein concentrations , 1991, Journal of the Neurological Sciences.

[10]  K. Blennow,et al.  Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. , 1993, European neurology.

[11]  E. Thompson,et al.  Isoelectric Focusing of Cerebrospinal Fluid Immunoglobulin G: An Annotated Update , 1990, Annals of clinical biochemistry.

[12]  V. Myllylä,et al.  Cerebrospinal fluid protein findings in various lower back pain syndromes , 1979, Acta neurologica Scandinavica.

[13]  H. Wisser,et al.  [Studies on the normal concentration range of total protein and the total protein fractions of the cerebrospinal fluid by electrophoresis on cellulose acetate (author's transl)]. , 1971, Zeitschrift fur klinische Chemie und klinische Biochemie.

[14]  B. Lush,et al.  Total and Differential Protein Levels in the Blood and Cerebrospinal Fluid in Rheumatoid Arthritis , 1951, Annals of the rheumatic diseases.

[15]  H. Reiber Flow rate of cerebrospinal fluid (CSF) — A concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases , 1994, Journal of the Neurological Sciences.

[16]  J. Fleming,et al.  A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking , 2009, Neurology.

[17]  J. Lott,et al.  Estimation of reference intervals for total protein in cerebrospinal fluid. , 1989, Clinical chemistry.

[18]  F. Fazekas,et al.  Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis , 2013, Multiple sclerosis.

[19]  O. Eeg‐Olofsson,et al.  CONCENTRATIONS OF CSF PROTEINS AS A MEASURE OF BLOOD BRAIN BARRIER FUNCTION AND SYNTHESIS OF IgG WITHIN THE CNS IN ‘NORMAL’ SUBJECTS FROM THE AGE OF 6 MONTHS TO 30 YEARS , 1981, Acta paediatrica Scandinavica.

[20]  Hansotto Reiber,et al.  Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs , 2001, Journal of the Neurological Sciences.

[21]  H. Rieder,et al.  [The Cu-Folin method for determination of the total protein content in the cerebrospinal fluid]. , 1962, Klinische Wochenschrift.

[22]  K. Breebaart,et al.  Investigation of Reference Values of Components of Cerebrospinal Fluid , 1978, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[23]  J. Kaye,et al.  Cerebrospinal fluid production is reduced in healthy aging , 1990, Neurology.

[24]  N. Gilhus,et al.  Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force , 2006, European journal of neurology.

[25]  P. Jung,et al.  Normalwerte des Totalproteins im Lumballiquor; Alters-, Geschlechts- und Umweltabhängigkeit , 1973, Klinische Wochenschrift.

[26]  O. Gilland LUMBAR CEREBROSPINAL FLUID TOTAL PROTEIN IN HEALTHY SUBJECTS , 1967, Acta neurologica Scandinavica.

[27]  C. J. Brackenridge Cerebrospinal fluid protein fractions in health and disease , 1962, Journal of clinical pathology.